BiotechTube
Home/Sandoz/Keren Haruvi
KH

Keren Haruvi

President, Sandoz North America

Sandoz

Roles

President, Sandoz North AmericaatSandoz
President, Sandoz North AmericaatSandoz Group

Therapeutic Areas

OncologyImmunologyAnti-infectivesOphthalmologyCentral Nervous SystemCardiovascularDermatology

Sandoz Pipeline

DrugIndicationPhase
Biosimilar DenosumabOsteoporosis, Bone Loss (Prolia/Xgeva)Regulatory Review
Biosimilar NivolumabVarious Cancers (Opdivo)Phase III
Biosimilar PembrolizumabVarious Cancers (Keytruda)Phase III
Biosimilar DupilumabAtopic Dermatitis, Asthma (Dupixent)Phase III
Biosimilar UstekinumabPsoriasis, Crohn's Disease (Stelara)Phase III
Biosimilar AfliberceptOphthalmology (Eylea)Phase III

Leadership Team at Sandoz

RS
Richard Saynor
Chief Executive Officer
RS
Remco Steenbergen
Chief Financial Officer
PB
Pierre Bourdage
President, Sandoz International
RG
Rebecca Guntern
Head of Strategy & Innovation
GD
Glenn D. Gormley, MD, PhD
Chairman of the Board
View full Sandoz profile